ATRX and neuroblastoma: In order to study the molecular role of different ATRX aberrations in neuroblastoma, we created isogenic ATRX knock-out (KO) and several distinct in-frame MEDs, including some rare deletions, in neuroblastoma cell line and tumoroid models.